Background: Adjuvant therapies have been approved for patients with AJCC (American Joint Committee on Cancer) stage III and stage IV cutaneous melanoma (CM) after complete resection. These therapies might also be indicated for patients with high-risk stage II CM. Material and methods: We included patients diagnosed with stage II melanoma between 2000 and 2016 and for which primary tumour tissue was available. The prognostic value of the 11gene expression profiling score (GEPS) was evaluated as a dichotomized parameter (GEPS 0 vs. >0). Endpoints of the analysis were melanoma specific survival (MSS), distant metastasis-free survival (DMFS) and relapse-free survival (RFS). Results: GEPS was determined in 245 patients ranging between À0.7 and 3.53. A total of 111 females and 134 males were included; the median follow-up was 41 months. Kaplan Meier analyses showed statistically significant survival differences between patients with high GEPS (n Z 154) and low GEPS (n Z 91) for MSS (p Z 0.018), DMFS (p Z 0.005) and RFS (p Z 0.009). The 5-year and 10-year MSS was 92% in the low-GEPS and 82% and 67% in
Rhodobacter capsulatus is able to grow with N 2 as the sole nitrogen source using either a molybdenum-dependent or a molybdenum-free iron-only nitrogenase whose expression is strictly inhibited by ammonium. Disruption of the fdxD gene, which is located directly upstream of the Mo-nitrogenase genes, nifHDK, abolished diazotrophic growth via Mo-nitrogenase at oxygen concentrations still tolerated by the wild type, thus demonstrating the importance of FdxD under semiaerobic conditions. In contrast, FdxD was not beneficial for diazotrophic growth depending on Fe-nitrogenase. These findings suggest that the 2Fe2S ferredoxin FdxD specifically supports the Mo-nitrogenase system, probably by protecting Mo-nitrogenase against oxygen, as previously shown for its Azotobacter vinelandii counterpart, FeSII. Expression of fdxD occurred under nitrogen-fixing conditions, but not in the presence of ammonium. Expression of fdxD strictly required NifA1 and NifA2, the transcriptional activators of the Mo-nitrogenase genes, but not AnfA, the transcriptional activator of the Fe-nitrogenase genes. Expression of the fdxD and nifH genes, as well as the FdxD and NifH protein levels, increased with increasing molybdate concentrations. Molybdate induction of fdxD was independent of the molybdate-sensing regulators MopA and MopB, which repress anfA transcription at micromolar molybdate concentrations. In this report, we demonstrate the physiological relevance of an fesII-like gene, fdxD, and show that the cellular nitrogen and molybdenum statuses are integrated to control its expression.
Many enzymes require the molybdenum cofactor, Moco. Under Mo-limiting conditions, the high-affinity ABC transporter ModABC permits molybdate uptake and Moco biosynthesis in bacteria. Under Mo-replete conditions, Escherichia coli represses modABC transcription by the one-component regulator, ModE, consisting of a DNA-binding and a molybdate-sensing domain. Instead of a full-length ModE protein, many bacteria have a shorter ModE protein, ModE(S) , consisting of a DNA-binding domain only. Here, we asked how such proteins sense the intracellular molybdenum status. We show that the Agrobacterium tumefaciens ModE(S) protein Atu2564 is essential for modABC repression. ModE(S) binds two Mo-boxes in the modA promoter as shown by electrophoretic mobility shift assays. Northern analysis revealed cotranscription of modE(S) with the upstream gene, atu2565, which was dispensable for ModE(S) activity. To identify genes controlling ModE(S) function, we performed transposon mutagenesis. Tn5 insertions resulting in derepressed modA transcription mapped to the atu2565-modE(S) operon and several Moco biosynthesis genes. We conclude that A. tumefaciens ModE(S) activity responds to Moco availability rather than to molybdate concentration directly, as is the case for E. coli ModE. Similar results in Sinorhizobium meliloti suggest that Moco dependence is a common feature of ModE(S) regulators.
Rhodobacter capsulatus fixes atmospheric dinitrogen via two nitrogenases, Mo-and Fe-nitrogenase, which operate under different conditions. Here, we describe the functions in nitrogen fixation and regulation of the rcc00574 (cooA) and rcc00575 (cowN) genes, which are located upstream of the structural genes of Mo-nitrogenase, nifHDK. Disruption of cooA or cowN specifically impaired Mo-nitrogenase-dependent growth at carbon monoxide (CO) concentrations still tolerated by the wild type. The cooA gene was shown to belong to the Mo-nitrogenase regulon, which is exclusively expressed when ammonium is limiting. Its expression was activated by NifA1 and NifA2, the transcriptional activators of nifHDK. AnfA, the transcriptional activator of Fe-nitrogenase genes, repressed cooA, thereby counteracting NifA activation. CooA activated cowN expression in response to increasing CO concentrations. Base substitutions in the presumed CooA binding site located upstream of the cowN transcription start site abolished cowN expression, indicating that cowN regulation by CooA is direct. In conclusion, a transcription factor-based network controls cowN expression to protect Mo-nitrogenase (but not Fe-nitrogenase) under appropriate conditions.
Rhodobacter capsulatus is capable of synthesizing two nitrogenases, a molybdenum-dependent nitrogenase and an alternative Mo-free iron-only nitrogenase, enabling this diazotroph to grow with molecular dinitrogen (N 2 ) as the sole nitrogen source. Here, the Mo responses of the wild type and of a mutant lacking ModABC, the high-affinity molybdate transporter, were examined by proteome profiling, Western analysis, epitope tagging, and lacZ reporter fusions. Biological nitrogen fixation (BNF) is a central process in the global nitrogen cycle, which converts chemically inert atmospheric dinitrogen to ammonia, a bioavailable form of nitrogen. BNF is catalyzed by complex metalloenzymes called nitrogenases, which are exclusively found in diazotrophic bacteria and archaea but not in eukaryotes (1). All diazotrophs synthesize a molybdenum-dependent nitrogenase containing an iron-molybdenum cofactor, FeMoco. In addition to Mo-nitrogenases, some bacteria synthesize alternative Mo-free nitrogenases, which contain either an iron-vanadium cofactor, FeVco, or an iron-only cofactor, FeFeco (2). Alternative nitrogenases are less efficient than Monitrogenases in terms of consumption of reducing power and ATP per molecule of N 2 fixed (3, 4). Consequently, diazotrophs preferentially utilize Mo-nitrogenase as long as sufficient molybdate, the only bioavailable form of molybdenum, is available. To support Mo-nitrogenase activity under Mo-limiting conditions, most diazotrophs synthesize a high-affinity molybdate transporter, ModABC (1).The purple nonsulfur alphaproteobacterium Rhodobacter capsulatus is known for its metabolic versatility, and it has been used for decades as a model organism to study photosynthesis, hydrogen production, and nitrogen fixation (5-9). In particular, it is capable of using light energy to generate the ATP required for the energetically demanding nitrogen fixation process. R. capsulatus synthesizes two nitrogenases, namely, a Mo-nitrogenase and a Fenitrogenase but no V-nitrogenase (10, 11). The synthesis and activity of the two nitrogenases are controlled at the transcriptional, translational, and posttranslational levels by a regulatory cascade responding to ammonium and Mo availability (8, 9). Upon ammonium limitation, the nitrogen regulatory protein NtrC becomes activated by phosphorylation. In turn, NtrC-P activates transcription of nifA and anfA, which encode the transcription activators of Mo-nitrogenase and Fe-nitrogenase genes, respectively. At high Mo concentrations, anfA transcription is repressed by two structurally and functionally related Mo-responsive regu-
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.